Ahead of next month’s Healthcare Distribution Alliance Business and Leadership Conference, Chip Davis, president and chief executive officer of the association, tells this week’s Video Forum about the prevailing attitude in the industry. Full implementation of the Drug Supply Chain Security Act later this year, the challenge of coping with current shortages of some medications,
In this week’s Video Forum, Chip Davis, president and chief executive officer of the Healthcare Distribution Alliance, talks about the resilience the pharmaceutical supply has shown during the COVID pandemic, and the lessons that the experience of the past 14 and a half months holds for the future. In addition, he addresses the ongoing implementation
WASHINGTON — Prescription abandonment is sharply higher for branded drugs than generic drugs, a new annual report commissioned by the Association for Accessible Medicines (AAM) found. AAM said Monday that abandonment — defined as the failure to pick up a new script — was nearly three times as high for brand-name drugs as for generics